Average Co-Inventor Count = 7.86
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (28 from 1,152 patents)
2. Vertex Pharmaceuticals Incoropated (1 from 1 patent)
29 patents:
1. 12421251 - Cystic fibrosis transmembrane conductance regulator modulating agents
2. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
3. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator
4. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
5. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator
6. 11203571 - Sulfonamides as modulators of sodium channels
7. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
8. 10793547 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
9. 10758534 - Modulators of cystic fibrosis transmembrane conductance regulator
10. 10738030 - Modulators of cystic fibrosis transmembrane conductance regulator
11. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
12. 10258624 - Modulators of cystic fibrosis transmembrane conductance regulator
13. 9782408 - Modulators of cystic fibrosis transmembrane conductance regulator
14. 8883781 - Thienopyrimidines useful as modulators of ion channels
15. 8865771 - Amides useful as inhibitors of voltage-gated sodium channels